Verve Therapeutics Inc.
(VERV)
undefined
undefined%
At close: undefined
5.81
1.57%
After-hours Dec 13, 2024, 06:09 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | 11.76M | 1.94M | - | - | - |
Cost of Revenue | 5.46M | 6.71M | 3.38M | 1.33M | 106.00K |
Gross Profit | 6.30M | -4.77M | -3.38M | -1.33M | -106.00K |
Operating Income | -223.12M | -165.69M | -87.07M | -40.63M | -13.64M |
Interest Income | - | 6.87M | 142.00K | 162.00K | 278.00K |
Pretax Income | -199.79M | -157.33M | -120.31M | -45.70M | -19.30M |
Net Income | -200.07M | -157.39M | -118.64M | -45.54M | -19.02M |
Selling & General & Admin | 49.94M | 37.53M | 18.86M | 5.26M | 2.50M |
Research & Development | 184.95M | 130.09M | 68.20M | 35.37M | 11.14M |
Other Expenses | - | 1.49M | -33.39M | -5.24M | -5.93M |
Operating Expenses | 234.88M | 167.63M | 87.07M | 40.63M | 13.64M |
Interest Expense | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 234.88M | 167.63M | 87.07M | 40.63M | 13.64M |
Income Tax | 275.00K | 53.00K | -1.68M | -162.00K | -278.00K |
Shares Outstanding (Basic) | 64.18M | 54.02M | 48.51M | 48.22M | 48.22M |
Shares Outstanding (Diluted) | 64.18M | 54.02M | 48.51M | 48.22M | 48.22M |
EPS (Basic) | -3.12 | -2.91 | -2.45 | -0.94 | -0.39 |
EPS (Diluted) | -3.12 | -2.91 | -2.45 | -0.94 | -0.39 |
EBITDA | -217.67M | -162.88M | -85.53M | -39.30M | -13.54M |
Depreciation & Amortization | 5.46M | 6.71M | 3.38M | 1.33M | 106.00K |